Anti-myeloma activity and molecular logic operation by Natural Killer cells in microfluidic droplets
{{output}}
Immune-targeted therapies that activate effector lymphocytes such as Natural Killer (NK) cells are currently being investigated for the treatment of Multiple myeloma (MM), the second most common form of hematological cancer. However, individual NK cells are hi... ...
